Search

Your search keyword '"Service des maladies infectieuses"' showing total 4,540 results

Search Constraints

Start Over You searched for: Author "Service des maladies infectieuses" Remove constraint Author: "Service des maladies infectieuses"
4,540 results on '"Service des maladies infectieuses"'

Search Results

1. Staphylococcus aureus endocarditis: Identifying prognostic factors using a method derived from morbidity and mortality conferences

2. Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML

3. Nationwide survey of hospital antibiotic stewardship programs in France

4. Kinetics of Hepatitis B Core–Related Antigen and Anti–Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus–Hepatitis B Coinfection

5. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

6. Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study

7. French national cohort of first use of dalbavancin: A high proportion of off-label use

8. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

9. Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia

10. Practices, organisation, and regulatory aspects in advising on antibiotic prescription: the international ESCMID AntibioLegalMap survey

11. Cervical osteomyelitis: A new identity of dreaded complication following pharyngeal cancer treatment

12. Role of super-spreader phenomenon in a Covid-19 cluster among healthcare workers in a Primary Care Hospital

13. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

14. Chronic use of Renin‐Angiotensin‐Aldosterone‐System blockers and mortality in COVID‐19: a multicenter prospective cohort and literature review

15. Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies

16. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

17. Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study

18. Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy

19. No evidence of sexual transmission of HEV among individuals using HIV pre‐exposure prophylaxis

20. E-health. Patterns of use and perceived benefits and barriers among people living with HIV and their physicians. Part 1: Information retrieval on the Internet and social networks

21. Sexual transmission of an extensively drug-resistant HIV-1 strain

22. Post–COVID-19 chronic symptoms: a postinfectious entity?

23. Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort

24. Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen

25. Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir

26. Infective endocarditis related to unusual microorganisms: a prospective population-based study

27. Rilpivirine in HIV-1-positive women initiating pregnancy

28. Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV

29. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015

30. Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool

31. Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis

32. HCV or HBV coinfection and lymphoma risk in people living with HIV

33. Is Rifampin Use Associated With Better Outcome in Staphylococcal Prosthetic Valve Endocarditis? A Multicenter Retrospective Study

34. Risk of Severe Bacterial Infection in People Living Human Immunodeficiency Virus Infection in the Combined Antiretroviral Therapy Era

35. Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat’AIDS Cohort Study

36. Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

37. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome

38. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

39. Modelling Tetraselmis sp. growth-kinetics and optimizing bioactive-compound production through environmental conditions

40. Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy

41. Failure of antiviral therapy with brincidofovir in non-HIV progressive multifocal leukoencephalopathy

42. Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France

43. [Erratum to 'Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies' [Med. Mal. Infect. 49 (2019) 296-317]]

44. Management and treatment of uncomplicated imported malaria in adults. Update of the French malaria clinical guidelines

45. Essential and Forgotten antibiotics: an inventory in low- and middle-income countries

46. Comparison of antimicrobial stewardship programmes in acute-care hospitals in four European countries: A cross-sectional survey

47. Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies

48. Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM

49. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies

50. Prognosis of Streptococcus pneumoniae endocarditis in France, a multicenter observational study (2000–2015)

Catalog

Books, media, physical & digital resources